Neuroprotective Effects of Fingolimod in a Cellular Model of Optic Neuritis
Visual dysfunction resulting from optic neuritis (ON) is one of the most common clinical manifestations of multiple sclerosis (MS), characterized by loss of retinal ganglion cells, thinning of the nerve fiber layer, and inflammation to the optic nerve. Current treatments available for ON or MS are o...
Enregistré dans:
Auteurs principaux: | Amritha A. Candadai, Fang Liu, Arti Verma, Mir S. Adil, Moaddey Alfarhan, Susan C. Fagan, Payaningal R. Somanath, S. Priya Narayanan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/84d2577ff1f94fce89aef8faa6029b1e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosis
par: Jagadeswara Rao Earla, et autres
Publié: (2021) -
Neuritis óptica en niños: Experiencia clínica en 13 años
par: Siebert V,Alejandra, et autres
Publié: (2009) -
Comparison of the Structure and Function of the Retina and the Optic Nerve in Patients with a History of Multiple Sclerosis-Related Demyelinating Retrobulbar Optic Neuritis Treated and Not Treated with Systemic Steroid Therapy
par: Nowacka B, et autres
Publié: (2021) -
Retinal nerve fiber layer thickness in multiple sclerosis with and without optic neuritis: a four-year follow-up study from Oman
par: Abdullah S. Al-Mujaini, et autres
Publié: (2021) -
Long-term structural retinal changes in patients with optic neuritis related to multiple sclerosis
par: Andersen MR, et autres
Publié: (2017)